Page 135 - ar2012

(C) Signifcant non-cash transactions
On 29 April 2011 and 1 November 2011, the Trust issued 629,794 units and 308,526 units at an issue price of $1.9943 and $2.0021 per
unit as payment for acquisition fees to the Manager in relation to the acquisition of Neuros & Immunos and Z-Link, respectively. On 16
June 2011 and 15 December 2011, the Trust also issued 1,301,946 units and 1,455,280 units at an issue price of $1.9903 and $1.9547
per unit, respectively, as payment of 20% of the base management fees. On 4 October 2011, the Trust issued 902,713 units at an issue
price of $2.0527 as payment for development management fee for the purchase of a development site at Fusionopolis awarded by
JTC.
In the previous fnancial year, the Trust issued 1,361,125 new units on 29 June 2010 and 1,160,431 new units on 15 December 2010
at an issue price of $1.8780 and $2.1110 per unit, respectively, as payment of 20% of the base management fees. On 29 June 2010,
the Trust also issued 617,678 new units at an issue price of $1.8780 as payment for acquisition fee to the Manager in relation to the
acquisition of DBS Asia Hub.
The above issue prices were determined based on the volume weighted average traded price for all trades done on Singapore
Exchange Securities Trading Limited (“SGX-ST”) in the ordinary course of trading for 10 business days immediately preceding the
respective date of issue of the new units.
CONSOLIDATED STATEMENT OF CASH FLOWS
Year ended 31 March 2012
The accompanying notes form an integral part of these fnancial statements.
135
A DECADE OF ENABLING BUSINESSES